Absorption |
Blood-Brain Barrier | BBB- | 0.9831 |
Human Intestinal Absorption | HIA+ | 0.9514 |
Caco-2 Permeability | Caco2- | 0.8224 |
P-glycoprotein Substrate | Substrate | 0.6544 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8463 |
Non-inhibitor | 0.8516 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9556 |
Distribution |
Subcellular localization | Mitochondria | 0.7834 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7592 |
CYP450 2D6 Substrate | Non-substrate | 0.8961 |
CYP450 3A4 Substrate | Substrate | 0.6828 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8927 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9021 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9232 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8827 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7560 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7422 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9943 |
Non-inhibitor | 0.7174 |
AMES Toxicity | Non AMES toxic | 0.8898 |
Carcinogens | Non-carcinogens | 0.8250 |
Fish Toxicity | High FHMT | 0.9755 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9736 |
Honey Bee Toxicity | Low HBT | 0.6497 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.7687 |
Carcinogenicity (Three-class) | Non-required | 0.6725 |